Sanofi 2008 SR
The report outlines Sanofi-Aventis' sustainability strategy for 2008, structured around four pillars: Patient 21, Ethics 21, People 21, and Planet 21. Key highlights include the launch of the ASAQ malaria treatment in 20 sub-Saharan African countries and the intensification of efforts against counterfeit drugs. The company reported a 10% reduction in CO2 emissions per unit produced since 2005 and achieved a 15% renewable energy share in its total electricity consumption. Social initiatives focused on diversity, with women representing 46.7% of the total workforce and 44.5% of management positions.
Company: Sanofi
Sector: Health Care
Country: France
Year: 2008
Type: SR
Pages: 44
Back to company
Sanofi
Sustainability Report
The report outlines Sanofi-Aventis' sustainability strategy for 2008, structured around four pillars: Patient 21, Ethics 21, People 21, and Planet 21. Key highlights include the launch of the ASAQ malaria treatment in 20 sub-Saharan African countries and the intensification of efforts against counterfeit drugs. The company reported a 10% reduction in CO2 emissions per unit produced since 2005 and achieved a 15% renewable energy share in its total electricity consumption. Social initiatives focused on diversity, with women representing 46.7% of the total workforce and 44.5% of management positions.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2008
Reporting Period
Jan 1, 2008 - Dec 31, 2008
Fiscal Year
2008
Published
Mar 3, 2009
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women in Management
Employees